Understanding the latest cancer screening guidelines is essential for healthcare professionals to ensure the provision of optimal patient care. These guidelines are often updated based on new research findings and advancements in diagnostic technologies.
The American Cancer Society recommends annual mammograms for women aged 45-54 and biennial mammograms for women aged 55 and older. Women with a high risk, such as a family history of breast cancer, should consider getting screened earlier and more frequently.
The U.S. Preventive Services Task Force (USPSTF) suggests men aged 55-69 discuss with their physicians the potential benefits and harms of prostate-specific antigen (PSA) screening. For men 70 and above, routine PSA screening is not recommended.
For colorectal cancer, the USPSTF recommends screening for adults aged 50-75 using high-sensitivity fecal occult blood tests, sigmoidoscopy, or colonoscopy. Adults aged 76-85 should make individual decisions based on their overall health and prior screening history.
Low-dose computed tomography (LDCT) is recommended annually for individuals aged 55-80 with a 30 pack-year smoking history, and who currently smoke or have quit within the past 15 years, according to the USPSTF.
The USPSTF recommends screening for cervical cancer in women aged 21-65 years with cytology (Pap smear) every three years or, for women aged 30-65 years, screening with a combination of cytology and human papillomavirus (HPV) testing every five years.
Staying updated with the latest cancer screening guidelines is crucial for healthcare professionals to provide evidence-based care. It is important to individualize screening decisions based on the patient's risk factors, preferences, and overall health status.
1.
Early cancer detection during pregnancy and the postpartum period may be aided by breast milk examination.
2.
Global warming could be driving up women's cancer risk, find researchers
3.
Use of social media during pregnancy may increase depression.
4.
Pickleball program boosts health and wellness for cancer survivors, study finds
5.
Researchers can now forecast how prostate cancer bone metastases will react to radium-223 treatment.
1.
The Mysterious Pain of Scrotal Hematoma: A Guide to Diagnosis and Treatment
2.
Base Editing for Rare Blood Diseases: Mechanisms, Clinical Applications, and Future Directions
3.
Immune Escape Landscapes in Solid Tumors
4.
Case Study: The Role of Machine Learning in the Detection of Skin Cancer
5.
How EPCORITAMAB is Revolutionizing the Treatment of Cancer
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL
2.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
3.
How Nutrition Can Support Patients During Cancer Care
4.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
5.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation